regenerative medicine
On the battlefield: MoD contracts Plasticell to develop regenerative medicines to treat combat injuries
Developer of stem cell technologies and regenerative medicines, Plasticell, has been contracted by the Ministry of Defence (MoD) in a pilot programme to develop regenerative medicines for the treatment of injuries resulting from combat or terrorism. Read more
New method has potential for regenerative medicine, note researchers
It is now possible to accurately predict how one subpopulation of cells can be converted into another thanks to a new computational method, according to Luxembourg researchers. Read more
ISCT announces support of FDA’s new framework for regenerative medicine
The International Society for Cellular Therapy (ISCT) has stated its support of the US Food and Drug Administration’s (FDA’s) new comprehensive Regenerative Medicine Policy Framework. Read more
Partnership formed for regenerative medicines
The CGT Catapult has signed a Memorandum of Understanding (MoU) with the FIRM in Japan, demonstrating a shared ambition to accelerate research and commercialisation of regenerative medicine. Read more
Sartorius and Science to award a prize for regenerative medicine and cell therapy
The Sartorius and Science Prize for Regenerative Medicine & Cell Therapy is focused towards scientists advancing research within the relevant fields, with the winner receiving $25,000 in prize money and being published in Science magazine Read more
Regenerative medicine bringing pharma and medtech closer together
Regenerative medicine is redefining medical technology synergies by combining stem cell technology with tissue engineering. Read more
Avita Medical launches regenerative medicine range
Avita Medical, a regenerative medicine company specialising in new treatments for wounds and skin defects, has announced the launch of ReGenerCell for chronic wounds and ReNovaCell for repigmentation Read more
Quick determination of cell culture surfaces
Orla Protein Technologies has developed an efficient means of determining the optimum protein surface required for different cell culture applications and research tasks. Read more
CiMaas and PharmaCell enter collaboration
CiMaas, a developer of cellular immunotherapy for cancer, and PharmaCell, a contract manufacturer for cellular therapies and regenerative medicine in Europe, are collaborating in the clinical development of CiMaas’ products. Read more
AMSBIO launches exosomes for regenerative medicine research
A new range of human exosomes has been launched by AMSBIO for regenerative medicines research. Derived from placental and adipose stem cells, they are ideally suited for wound healing, stem cell differentiation and tissue regeneration applications. Read more
New CSO furthers Plasticell's regenerative medicine expertise
Cell therapies developer Plasticell has recruited Dr. Aaron Chuang chief scientific officer (CSO). Dr. Chuang takes on responsibility for preclinical therapeutic programmes and scientific oversight of collaborations and alliances, as well as external Read more
Regenerative medicine market is expected to reach $67.6 billion, global, by 2020
The immense potential of these medicines in repairing or regenerating diseased organs is the major reason for intensive focus on research and development in this field. Read more
Can regenerative medicine be the cure for cancer and other deadly diseases?
Frost & Sullivan's Global Regenerative Medicine Market finds approval rates and clinical activity buzz point to regenerative medicine being attractive for investors. Read more
